Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

AcuNetx Announces Change in Trading Status

September 3, 2010 By Bio-Medicine.Org

TORRANCE, Calif., Sept. 3 /PRNewswire/ — AcuNetx, Inc. (OTC
Bulletin Board:
ANTXE) today announced that it had received a communication
from the Financial Industry Regulatory Authority (FINRA) to the
effect that its Common Stock would be removed from quotation on the
OTC Bulletin Board on September 3, 2010.

The letter indicated that FINRA took the action because AcuNetx
has been delinquent in its filings under the Exchange Act three
times in the past two years, and NASD Rule 6530 provides for
removal from quotation in this instance. AcuNetx has the right to
appeal the decision, and is considering whether to file such an
appeal.

Robert S. Corrigan, President of AcuNetx, said, “We plan to
continue filing reports and financial statements with the SEC, and
we expect that our stock will continue to be quoted and traded in
the over-the counter market (Pink Sheets).” He added, “Accordingly,
we believe this action will not have any effect on our
shareholders, and should have no effect on the liquidity of our
Common Stock.”

Corrigan explained that AcuNetx had timely filed its 10-Q for
the quarter ended June 30, 2010. However, since AcuNetx had earlier
dismissed its independent certified public accountants and has not
engaged new accountants, the financial statements in the 10-Q were
not reviewed by outside accountants, as contemplated by SEC
accounting rules. FINRA took the position that, because of this,
the filing was deficient.

“We are actively interviewing accounting firms, and plan to
retain a new firm in the coming weeks,” said Corrigan. “Once
retained, we will ask the new accountants to review our current
10-Q filings and amend them if necessary.”

About AcuNetx, Inc.:

AcuNetx markets a diverse line of diagnostic, analytical and
therapeutic tools for medical (audiologists, neurologists,
otolaryngologists and physical therapists as well as

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech